University of MD, Greenebaum Comprehensive Cancer Center

Baltimore, Maryland 21201

2 studies enrolling now · 5 studies all time

What they study most

Advanced Cancer, Bladder Cancer, High-risk Large B-cell Lymphoma (LBCL), Melanoma, Cutaneous Malignant, Metastatic Solid Tumors, Relapsed and/or Refractory B-cell Lymphoma, Solid Tumor, Urothelial Carcinoma

Studies at this site

• Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma — Recruiting now
• SUPRAME-ACTengine® IMA203 vs. Investigator's Choice of Treatment in Previously Treated, Unresectable or Metastatic Cutaneous Melanoma — Recruiting now
• Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma — Running, not enrolling
• Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy — Completed
• Study to Evaluate the Efficacy/Safety of IPI-549 in Combination With Nivolumab in Patients With Advanced Urothelial Carcinoma (MARIO-275) — Completed